A comparison of SARS-CoV-2 symptom prevalence, duration, and risk of hospitalisation among vaccinated individuals from the ZOE COVID Study during Omicron versus Delta variant dominant periods

Cristina Menni; Sebastien Ourselin; Alexander Hammers; Erika Molteni; Michela Antonelli; Carole  Sudre

A comparison of SARS-CoV-2 symptom prevalence, duration, and risk of hospitalisation among vaccinated individuals from the ZOE COVID Study during Omicron versus Delta variant dominant periods

Cristina Menni, Sebastien Ourselin, Alexander Hammers, Erika Molteni, Michela Antonelli, Carole Sudre

UCL University College London

Research output: Contribution to journal › Article › peer-review

489 Downloads (Pure)

Original language	English
Journal	The Lancet
Publication status	Accepted/In press - 16 Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Omicron_final_clean_14_02_2022Accepted author manuscript, 50.1 KB

Cite this

@article{d4d12d44df1f4f8e9ec9200fd59fd405,

title = "A comparison of SARS-CoV-2 symptom prevalence, duration, and risk of hospitalisation among vaccinated individuals from the ZOE COVID Study during Omicron versus Delta variant dominant periods",

author = "Cristina Menni and Sebastien Ourselin and Alexander Hammers and Erika Molteni and Michela Antonelli and Carole Sudre",

year = "2022",

month = feb,

day = "16",

language = "English",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

}

TY - JOUR

T1 - A comparison of SARS-CoV-2 symptom prevalence, duration, and risk of hospitalisation among vaccinated individuals from the ZOE COVID Study during Omicron versus Delta variant dominant periods

AU - Menni, Cristina

AU - Ourselin, Sebastien

AU - Hammers, Alexander

AU - Molteni, Erika

AU - Antonelli, Michela

AU - Sudre, Carole

PY - 2022/2/16

Y1 - 2022/2/16

M3 - Article

SN - 0140-6736

JO - The Lancet

JF - The Lancet

ER -